No abstract is available for this article. mehr
Um alle Funktionen dieser Seite zu nutzen, aktivieren Sie bitte die Cookies in Ihrem Browser.
my.bionity.com
Mit einem my.bionity.com-Account haben Sie immer alles im Überblick - und können sich Ihre eigene Website und Ihren individuellen Newsletter konfigurieren.
A series of diarylpyrazole clubbed dihydropyrimidine derivatives (J1–J30) was synthesized under microwave‐assisted heating conditions by employing Biginelli reaction methodology and utilizing triethylammonium acetate both as a catalyst and as reaction medium, leading towards a greener reaction pathway. The synthesized entities were screened for their antimalarial efficacy against a Plasmodium falciparum strain in vitro. The active entities (J9, J15, J21, J25, and J27) obtained out of the in vitro screening were further evaluated for their enzyme inhibitory potency against the Pf‐DHFR enzyme in vitro as well as in silico using Glide. Furthermore, the active scaffolds were tested for their cytotoxicity against Vero cells, proving their nontoxic behavior and selectivity. The ADME parameters were also evaluated and predicted in silico, indicating good oral bioavailability of the compounds.
Novel hybrid diarylpyrazole clubbed dihydropyrimidine motifs were synthesized under microwave irradiation using TEAA as reaction medium, and screened for their antimalarial efficacy, revealing five active scaffolds: J9, J15, J21, J25, and J27. Enzyme inhibitory studies against Pf‐DHFR proved their potency as dihydrofolate reductase inhibitors. The obtained ADME parameters predicted oral bioavailability of these active molecules.
Autoren: | Jaimin D. Bhatt, Chaitanya J. Chudasama, Kanuprasad D. Patel | |
Journal: | Archiv der Pharmazie | |
Jahrgang: | 2017 | |
Seiten: | n/a | |
DOI: | 10.1002/ardp.201700088 | |
Erscheinungsdatum: | 10.08.2017 |
No abstract is available for this article. mehr
Standardisation of inactivated influenza vaccines – learning from history
Abstract The single radial immunodiffusion assay has been the accepted method for determining the potency of inactivated influenza vaccines since 1978. The world‐wide adoption of this assay for vaccine standardisation was facilitated through collaborative studies that demonstrated a high ... mehr
1918 pandemic morbidity: the first wave hits the poor, the second wave hits the rich
Abstract Background Whether morbidity from the 1918‐19 influenza pandemic discriminated by socioeconomic status has remained a subject of debate for 100 years. In lack of data to study this issue recent literature have hypothesized that morbidity was “socially neutral”. Objectives ... mehr